ENTRADA THERAPEUTICS, INC. (TRDA) Net Margin
- 2026-06-30: Net Margin -4762.03%.
- 2026-03-31: Net Margin -4539.09%.
- 2025-12-31: Net Margin -3014.93%.
- 2025-09-30: Net Margin -2734.45%.
Complete source-backed net margin history.
- Available history
- 2023-03-31 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -4762.03% |
| 2026-03-31 | -4539.09% |
| 2025-12-31 | -3014.93% |
| 2025-09-30 | -2734.45% |
| 2025-06-30 | -2210.41% |
| 2025-03-31 | -84.39% |
| 2024-12-31 | 3.02% |
| 2024-09-30 | -71.70% |
| 2024-06-30 | 58.11% |
| 2024-03-31 | 39.74% |
| 2023-12-31 | -22.81% |
| 2023-09-30 | 81.08% |
| 2023-06-30 | -142.70% |
| 2023-03-31 | -26.42% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -565.48% |
| 2024-12-31 | 31.13% |
| 2023-12-31 | -5.18% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |